• Nie Znaleziono Wyników

Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum

N/A
N/A
Protected

Academic year: 2022

Share "Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum"

Copied!
4
0
0

Pełen tekst

(1)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e Nr 07/2013

620

Ginekol Pol. 2013, 84, 620-623

P R A C E O R Y G I N A L N E

położnictwo

Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum

Hormon wzrostu łożyskowy, przysadkowy hormon wzrostu,

insulinopodobny czynnik wzrostu oraz grelina w surowicy krwi kobiet ciężarnych

$QGU]HM.ĊG]LD

1

$JDWD7DUND

2

(OĪELHWD3HWULF]NR



'RPLQLN3UXVNL



.LQJD,ZDQLHF



1 Department of Clinical Auxology and Pediatrics Nursing, Division of Diabetology and Obesity of the Developmental Age, Poznan University of Medical Sciences, Poland

2 Institute of Practical Obstetrics Science, Poznan University of Medical Sciences, Poland

3 Clinic of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University, Poland

4 Department of Perinatology and Gynecology, Division of Gynecology, Poznan University of Medical Sciences, Poland

Abstract

Objectives: The aim of this work is to evaluate levels of placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum before, during and after delivery. Furthermore, the aim is to search for links and interdependence of GH1, PGH and IGF-I concentrations.

Material and methods: Seventy nine blood samples were taken one to two hours before, during and half an hour after expulsion of placenta. All proteins studied were determined by ELISA method, using ELISA Kit.

Results: The highest PGH concentration and IGF-I concentration in pregnant women’s blood serum was observed before delivery, while GH1 concentration was lowest. During and after delivery PGH and IGF-I concentration decreased proportionately and pituitary growth hormone concentration increased accordingly. About half an hour after delivery of the placenta, GH1 concentration was highest.

Conclusions: In pregnant women’s blood there is a metabolic interdependence between PGH and IGF-I. Their concentration increases proportionately during pregnancy, and decreases after delivery. It appears that labor and delivery releases GH1 blockade, which level rises three-fold during delivery. After parturition its role and concentration returns to levels before pregnancy.

Key words: pregnant women / PGH / GH1 / IGF-I / ghrelin / ElooG VerXm /

Otrzymano: 05.11.2012

Zaakceptowano do druku: 10.06.2013 Corresponding author:

Andrzej Kędzia

Department of Clinical Auxology and Pediatrics Nursing, Division of Diabetology and Obesity of the Developmental Age, Poznan University of Medical Sciences

Szpitalna 27/33, 60-572 Poznan, Poland Tel.: +48 61 849 12 65; Fax: +48 61 848 33 62 e-mail: akedzia@ump.edu.pl

(2)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e

Nr 07/2013

621

P R A C E O R Y G I N A L N E położnictwo Andrzej Kędzia et al. Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum.

Ginekol Pol. 2013, 84, 620-623

Introduction

3ODFHQWDO JURZWK KRUPRQH 3*+  ZDV GLVFRYHUHG DQG

GHVFULEHGLQ1E\+HQQHQHWDO>12@,WVKRZVDKLJKGHJUHHRI

KRPRORJ\ZLWKSLWXLWDU\JURZWKKRUPRQH *+1 7KHGLIIHUHQFH

EHWZHHQSODFHQWDOJURZWKKRUPRQHDQGSLWXLWDU\JURZWKKRUPRQH

OLHVLQ1DPLQRDFLGVDQG1JO\FRV\ODWLRQVLWHV>1@,WLVDSURGXFW

RI *+9 JHQH ZKLFK EHORQJV WR WKH IDPLO\ RI ¿YH JURZWK

KRUPRQHJHQHVORFDWHGRQWKHORQJDUPRIFKURPRVRPH1>@

7KLVKRUPRQHLVV\QWKHVL]HGDQGVHFUHWHGE\V\QF\WLRWURSKREODVW

DQGH[WUDYLOORXVF\WRWURSKREODVW>@

6\QF\WLRWURSKREODVW FRYHUV IUHH YLOOL DQG UHOHDVHV 3*+

LQWR PDWHUQDO EORRGVWUHDP 7KLV SURWHLQ LV GHWHFWDEOH DV HDUO\

DV ¿YH WR HLJKW ZHHNV RI JHVWDWLRQ ,WV FRQFHQWUDWLRQ LQFUHDVHV

DQGUHDFKHVSHDNOHYHOVEHWZHHQDQGZHHNVRIJHVWDWLRQ

,W LV HOLPLQDWHG IURP WKH EORRGVWUHDP DIWHU SODFHQWDO H[SXOVLRQ

>@,WLVGHVFULEHGWKDWGXULQJSUHJQDQF\3*+SURJUHVVLYHO\

GLVSODFHV SLWXLWDU\ *+ IURP PDWHUQDO FLUFXODWLRQ WKH YDOXHV

RIZKLFKGHFUHDVHDVSUHJQDQF\SURJUHVVHV>@,QWKHSLWXLWDU\

JODQGRISUHJQDQWZRPHQWKHQXPEHURIVRPDWRWURSKVGHFUHDVHV

FRQVLGHUDEO\ WR WKH DGYDQWDJH RI 35/V\QWKHVL]LQJ FHOOV >

@ ,QVXOLQOLNH JURZWK IDFWRU DQG *+ FRQVWLWXWH NH\ JURZWK

IDFWRU DFWLQJ EDVHG RQ SULQFLSOH RI IHHGEDFN FRQFHQWUDWLRQV

7KLV HQGRFULQH PHFKDQLVP KDV EHHQ H[WHQVLYHO\ UHVHDUFKHG LQ

DGXOWVKRZHYHUOLWWOHLVNQRZQDERXWFKDQJHVRFFXUULQJGXULQJ

SUHJQDQF\

1XPHURXV DXWKRUV GUDZ DWWHQWLRQ WR WKH OLQN EHWZHHQ

JKUHOLQ DQG JURZWK KRUPRQH  JKUHOLQ LQGXFHV *+ VHFUHWLRQ

IURPSLWXLWDU\JODQGVRPDWRWURSKVERWKLQKXPDQVDOVRGXULQJ

IHWDOOLIHDQGLQH[SHULPHQWDODQLPDOV>1@,QDGGLWLRQJKUHOLQ

SDUWLFLSDWHV LQ WKH EUDLQLQWHVWLQH D[LV 7RJHWKHU ZLWK OHSWLQ LW

FUHDWHVDFRPSOHPHQWDU\V\VWHPZKLFKUHJXODWHVDQGLQIRUPVWKH

FHQWUDOQHUYRXVV\VWHPRIHQHUJHWLFVWDWHRIDQRUJDQLVP>111@

Aim of the study

7KH DLP RI WKH VWXG\ LV WR HYDOXDWH SURWHLQ FRQFHQWUDWLRQV

LQ SUHJQDQW ZRPHQ¶V EORRG VHUXP EHIRUH GXULQJ DQG DIWHU

GHOLYHU\ WKDW LV DIWHU H[SXOVLRQ RI WKH SODFHQWD )XUWKHUPRUH

ZHORRNIRUOLQNVDQGLQWHUGHSHQGHQFHRI*+13*+DQG,*),

FRQFHQWUDWLRQV

Materials and Methods

6WXGLHV ZHUH FRQGXFWHG RQ EORRG VDPSOHV FROOHFWHG IURP

SUHJQDQW ZRPHQ 7KH VDPSOHV ZHUH WDNHQ RQH WR WZR KRXUV

EHIRUH GXULQJ SDUWXULWLRQ DQG KDOI DQ KRXU DIWHU WKH H[SXOVLRQ

RISODFHQWD7RWDORIEORRGVDPSOHVFROOHFWHGIURPSUHJQDQW

ZRPHQ ZHUH LQYHVWLJDWHG 0RVW RI WKH SUHJQDQW ZRPHQ ZHUH

KHDOWK\DQGGLGQRWUHSRUWDQ\DLOPHQWV(LJKWSUHJQDQWZRPHQ

VXIIHUHG IURP W\SH , GLDEHWHV VL[ RI WKHP VXIIHUHG IURP FODVV

*1'0RQHIURP*2'0DQGRQHIURPFODVV&GLDEHWHV7KUHH

RIWKHZRPHQGHOLYHUHGSUHPDWXUHO\7KHUHPDLQLQJSUHJQDQFLHV

ZHUHIXOOWHUPRIZKLFKRQHZDVDWZLQSUHJQDQF\

7KHIROORZLQJKRUPRQHVZHUHPDUNHGLQEORRGVDPSOHVRI

SUHJQDQWZRPHQ

 SLWXLWDU\JURZWKKRUPRQH *+1

 SODFHQWDOJURZWKKRUPRQH 3*+

 LQVXOLQOLNHJURZWKIDFWRU ,*),

 DF\ODWHGJKUHOLQ

$OOWKHSURWHLQVZHUHPDUNHGXVLQJ(/,6$.LWV*+1DQG

,*), ZHUH DVVD\HG ZLWK 5 ' 6\VWHPV (/,6$ .LWV 5 '

6\VWHPV 0LQQHDSROLV 86$  3*+ SURWHLQ ZLWK D 8VFQ OLIH

6FLHQFH (/,6$ .LW 8VFQ OLIH 6FLHQFH :XKDQ &KLQD  DQG

JKUHOLQ ZDV DVVD\HG ZLWK D %LR9HQGRU (/,6$ .LW %LR9HQGRU

0RGULFH &]HFK 5HSXEOLF  DOO DFFRUGLQJ WR WKH PDQXIDFWXUHUV¶

UHFRPPHQGDWLRQV

Results

7DEOHEHORZVKRZVWKDWWKHKLJKHVWFRQFHQWUDWLRQRISODFHQWDO

JURZWKKRUPRQHLQSUHJQDQWZRPHQ¶VEORRGVHUXPZDVREVHUYHG

EHIRUHGHOLYHU\ZKLOHWKHFRQFHQWUDWLRQRIWKHSLWXLWDU\JURZWK

KRUPRQHZDVWKHORZHVW7KHFRQFHQWUDWLRQRILQVXOLQOLNHJURZWK

IDFWRUOLNHWKDWRI3*+ZDVKLJKHVWEHIRUHODERUDQGGHOLYHU\

'XULQJ DQG DIWHU GHOLYHU\ WKH 3*+ DQG ,*), FRQFHQWUDWLRQ

GHFUHDVHGDFFRUGLQJO\DQGWKHSLWXLWDU\JODQGKRUPRQHLQFUHDVHG

DFFRUGLQJO\$ERXWKDOIDQKRXUDIWHUSODFHQWDOH[SXOVLRQ3*+

Streszczenie

Cel pracy: Celem pracy jest ocena stężenia hormonu wzrostu łożyskowego PGH), przysadkowego hormonu wzrostu (GH1), insulinopodobnego czynnika wzrostu (IGF-1) i greliny w surowicy krwi kobiet ciężarnych przed porodem, w czasie porodu i po porodzie, a więc po wydaleniu łożyska. Poza tym poszukiwano powiązań współzależności pomiędzy stężeniami GH1, PGH, IGF-I.

Materiał i metody: Zbadano próbki krwi od 79 kobiet. Krew pobierano 1-2. godzin przed porodem, w czasie porodu i po wydaleniu łożyska. Wszystkie badane białka były oznaczane metodą ELISA z wykorzystaniem zestawów ELISA Kit.

Wyniki: Najwyższe stężenie PGH w surowicy krwi ciężarnych obserwowano przed porodem, natomiast stężenie przysadkowego GH1 w tym samym czasie było najniższe. Stężenie IGF-I podobnie jak PGH było najwyższe. W trakcie porodu i po porodzie stężenie PGH i IGF-I proporcjonalnie malało a stężenie hormonu wzrostu przysadkowego odpowiednio powiększało się. Pół godziny po wydaleniu łożyska GH1 wykazywał najwyższe stężenie.

Wnioski: We krwi kobiet ciężarnych istnieje współzależność metaboliczna pomiędzy PGH i IGF-I. Ich stężenia narastają proporcjonalnie w czasie ciąży i obniżają się po porodzie. Poród wydaje się uwalniać blokadę GH1, którego koncentracja trzykrotnie rośnie w czasie porodu. Po porodzie jego rola i stężenie wracają do warunków przed ciążą.

Słowa kluczowe: NoEiet\ FiĊĪarne / (PGH) / GH1 / IGF-I / grelina / surowica krwi /

(3)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e Nr 07/2013

622

P R A C E O R Y G I N A L N E położnictwo

Andrzej Kędzia et al. Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum.

Ginekol Pol. 2013, 84, 620-623

DQG ,*), FRQFHQWUDWLRQ ZDV ORZHVW ZKLOH *+1 FRQFHQWUDWLRQ

ZDVKLJKHVWDIWHUGHOLYHU\6WDWLVWLFDOO\VLJQL¿FDQWOHYHORI3*+

GLIIHUHQFH ZDV REVHUYHG EHWZHHQ VWXGLHG JURXSV S1 

7KHUHPDLQLQJKRUPRQHOHYHOVGLGQRWGHPRQVWUDWHVWDWLVWLFDOO\

VLJQL¿FDQWGLIIHUHQFHV 7DEOH, *KUHOLQFRQFHQWUDWLRQVGLGQRW

FKDQJHVLJQL¿FDQWO\GXULQJWKHWKUHHVWXGLHGVWDJHV

Discussion

2XU VWXGLHV VKRZ D GHFUHDVH LQ 3*+ FRQFHQWUDWLRQ GXULQJ

GHOLYHU\ SURJUHVVLRQ WR YHU\ ORZ OHYHOV DIWHU H[SXOVLRQ RI WKH

SODFHQWD &KHOODNRRW\ HW DO >@ PRQLWRUHG 3*+ FRQFHQWUDWLRQ

LQ SUHJQDQW ZRPHQ¶V EORRG E\ FROOHFWLQJ EORRG VDPSOHV VHYHQ

WLPHVGXULQJSUHJQDQF\DQGVKRZHGWKDWWKHFRQFHQWUDWLRQRIWKLV

KRUPRQHLQFUHDVHGIURP¿IWKWRWKZHHNRIJHVWDWLRQWKHQLWV

FRQFHQWUDWLRQJUDGXDOO\GHFUHDVHG,WVKLJKHVWFRQFHQWUDWLRQLV22

QJPO7KHUHDUHDWWHPSWVWRXVHSUHVHQFHRIKLJKFRQFHQWUDWLRQRI

WKLVKRUPRQHLQEORRGVHUXPGXULQJ¿UVWWULPHVWHURISUHJQDQF\

WR HVWLPDWH WKH ULVN RI 'RZQ 6\QGURPH >12@ 0RUHRYHU KLJK

FRQFHQWUDWLRQRI3*+DQG*+1ZDVDOVRGHVFULEHGLQSUHHFODPSWLF

SDWLHQWV >1 1@ 7KH PDLQ VRXUFH RI 3*+ LV WKH SODFHQWDO

WURSKREODVW DQG IRU GHFDGHV LW ZDV WKRXJKW WKDW WKLV SURWHLQ LV

ORFDWHGRQO\LQPDWHUQDOFLUFXODWLRQ,WZDVRQO\EHWZHHQ2

DQG2WKDWWKH¿UVWZRUNVDSSHDUHGZKLFKDOVRGHVFULEHGWKH

SUHVHQFHRIWKHSODFHQWDOJURZWKKRUPRQHLQWKHXPELOLFDOEORRG

RIQHZERUQVDQGLQWKHDPQLRWLFÀXLG>1111@,QRXUHDUOLHU

ZRUN LQ ZKLFK ZH HYDOXDWHG DPRQJ RWKHUV 3*+ DQG ,*),

OHYHOV LQ VHUXP RI XPELOLFDO EORRG ZH VKRZHG D FRUUHODWLRQ

EHWZHHQ,*),DQGERG\PDVVRIIXOOWHUPQHZERUQV0HDQZKLOH

3*+FRQFHQWUDWLRQZDVKLJKHULQSUHPDWXUHQHZERUQVDQGIXOO

WHUP ORZELUWKZHLJKW LQIDQWV WKDQ LQ QRUPDO SUHJQDQFLHV :H

SXW IRUZDUG D VXJJHVWLRQ WKDW KLJKHU 3*+ YDOXHV LQ WKH EORRG

RISUHPDWXUHQHRQDWHVDQGIXOOWHUPORZELUWKZHLJKWQHZERUQV

PD\EHFRQQHFWHGZLWKDFWLYDWLRQRIFRPSHQVDWRU\PHFKDQLVPV

LQFUHDVHG3*+VHFUHWLRQVWLPXODWHV,*),LQWKHSODFHQWDOWLVVXH

WKHUHE\ LQFUHDVLQJ LWV SUROLIHUDWLRQ DQG LQFUHDVLQJ ERG\ PDVV

RI QHZERUQV $W WKH VDPH WLPH RXU VWXGLHV VKRZHG D JUDGXDO

GHFUHDVH RI 3*+ DQG ,*), FRQFHQWUDWLRQV LQ WKH VHUXP RI

PDWHUQDOEORRGGXULQJGHOLYHU\XQWLOH[SXOVLRQRISODFHQWD$OVR

WKHEHKDYLRURIERWKSURWHLQVVWXGLHGVXJJHVWVWKDWWKHPDLQSODFH

RIWKHLUV\QWKHVLVLVWKHSODFHQWD+RZHYHUZHZRQGHULI3*+LV

H[FOXVLYHO\V\QWKHVL]HGE\WKHWURSKREODVW,ILWLVWKHQDTXHVWLRQ

DULVHVKRZGRHVLWJRLQWRWKHIHWDOFLUFXODWLRQ"

7KH SUHVHQFH RI P51$ RI *+9 JHQH FRGLQJ 3*+ LQ

K\GDWLGLIRUP PROH FKRULRFDUFLQRPD FXOWXUH DGHQRPD RI WKH

SLWXLWDU\ JODQG DQG WHVWLFXODU QHRSODVP ZDV GHVFULEHG LQ WKH

OLWHUDWXUH KRZHYHU WKHLU DXWKRUV ZHUH XQDEOH WR LGHQWLI\ WKLV

KRUPRQHLQEORRGVHUXPRIWKHVHSDWLHQWV>11@7KHSUREOHP

LVZKHWKHU3*+EHVLGHVEHLQJV\QWKHVL]HGE\WKHWURSKREODVWLV

DOVRV\QWKHVL]HGE\IHWDOFHOOVLWLVDQRSHQTXHVWLRQDQGUHTXLUHV

IXUWKHU LQGHSWK VWXGLHV $OO RXU VWXGLHV VXJJHVW WKDW WKHUH LV

D PHWDEROLF UHODWLRQ EHWZHHQ 3*+ DQG ,*), LQ ERWK WKH IHWDO

DQGPDWHUQDOFLUFXODWLRQ,QFLUFXODWLRQRISUHJQDQWZRPHQ3*+

SOD\VDVLPLODUUROHDVGRHVWKHSLWXLWDU\*+1LQDQDGXOWRUJDQLVP

ZLWKWKHH[FHSWLRQWKDWLWGRHVQRWIXQFWLRQLQDSXOVDWLOHPDQQHU

3ODFHQWDOJURZWKKRUPRQHDFWLYHO\VXSSUHVVHVSLWXLWDU\*+1

LQSUHJQDQWZRPHQ¶VEORRGVWUHDP,WVFRQFHQWUDWLRQDVZHOODV

WKDW RI ,*), LQFUHDVHV SURSRUWLRQDWHO\ ZLWK DGYDQFHPHQW RI

SUHJQDQF\ ZKLOH *+1 GHFUHDVHV WR DOPRVW ]HUR 0HDQZKLOH

GXULQJ ODERU DQG GHOLYHU\ WKH VLWXDWLRQ LV RSSRVLWH  3*+ DQG

,*),FRQFHQWUDWLRQGHFUHDVHVZKLOHSLWXLWDU\*+1FRQFHQWUDWLRQ

LQFUHDVHV ,W LV D ZHOO NQRZQ WKH IDFW WKDW GXULQJ SUHJQDQF\

WKH SLWXLWDU\ JODQG LV UHVWUXFWXUHG DQG HQODUJHG ZKLOH WKH WRWDO

QXPEHU RI VRPDWRWURSKV GHFUHDVHV WR WKH DGYDQWDJH RI FHOOV

WKDWV\QWKHVL]H35/6RPHDOVRVXJJHVWWKDWVRPDWRWURSKVPD\

WUDQVIRUPLQWR35/V\QWKHVL]LQJFHOOV>11@

$VIDUDVJKUHOLQLVFRQFHUQHGLWVFRQFHQWUDWLRQLQVWXGLHG

SUHJQDQW ZRPHQ¶V EORRG VHUXP GLG QRW VKRZ DQ\ FRQVLGHUDEOH

FKDQJHV ,Q EORRG VHUXP JKUHOLQ LV IRXQG LQ WZR IRUPV WKH

DF\ODWHG IRUP ZKLFK LV HQGRFULQHDFWLYH DQG WKH QRQDF\ODWHG

IURP ZKLFK LV HQGRFULQHLQDFWLYH *KUHOLQ SDUWLFLSDWHV LQ WKH

FRQWURO RI PHWDEROLF HQHUJ\ KRPHRVWDVLV ZKLFK UHJXODWHV

HQHUJ\ FRQVXPSWLRQ E\ LQÀXHQFLQJ DSSHWLWH PRGXODWLRQ RI

LPPXQRORJLFDOV\VWHPSLWXLWDU\VWLPXODWLRQRIWKHJRQDGDODQG

DGUHQDOD[LVDQGPDQ\RWKHUV>12@

Ta b l e I . Statistical analysis of results of hormone levels found in the peripheral circulation in women during peripartum period.

Hormone

%eIoreSDrWXrLWLon 'XrLnJSDrWXrLWLon $IWerSDrWXrLWLon

0eDn 6'

0eGLDn mLnmD[

0eDn 6'

0eGLDn mLnmD[

0eDn 6'

0eGLDn mLnmD[

3*+

>SJPO@

11427.3 (10582.4)

*6452,3 (5523.827280.6)

2701.7 (968.4)

*2819.1 (1006.74610.2)

586.3 (44.2)

*600.0 (495.4644.4)

*+1

>SJPO@

459.1 (239.4)

397.9 (240.4800.0)

1534.9 (1691.6)

1062.5 (96.67771.3)

1775.7 (2177.89)

845.2 (152.16342.9) ,*),

>QJPO@

166.1 (87.7)

135.5 (101.6291.8)

230.4 (136.8)

177.7 (99.2576.8)

193.5 (95.0)

165.6 (83.4363.6)

*KUHOLQ

>SJPO@

51.2 (15.3)

54.5 (30.165.7)

43.3 (33.9)

33.9 (6.4119.5)

37.5 (20.07)

33.0 (16.765.9)

*.UXVNDO:DOOLV 2QH :D\ $QDO\VLV RI 9DULDQFH RQ 5DQNV 30.001

(4)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e

Nr 07/2013

623

P R A C E O R Y G I N A L N E położnictwo Andrzej Kędzia et al. Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women’s blood serum.

Ginekol Pol. 2013, 84, 620-623

Conclusions

7RFRQFOXGHEDVHGRQWKHUHVXOWVZHREWDLQHGDQGWKHGDWD

SUHVHQWHGLQOLWHUDWXUHRQWKLVVXEMHFWLWFDQEHDVVXPHGWKDWLQ

SUHJQDQW ZRPDQ¶V EORRG WKHUH LV D PHWDEROLF LQWHUGHSHQGHQFH

RI3*+DQG,*),7KHUHLVDVWDWLVWLFDOO\VLJQL¿FDQWGLIIHUHQFH

LQ 3*+ OHYHOV EHWZHHQ VWXGLHV S1  ,WV FRQFHQWUDWLRQ

LQFUHDVHV SURSRUWLRQDOO\ GXULQJ SUHJQDQF\ XQWLO PHFKDQLVPV

RI FKLOGELUWK DUH DFWLYDWHG 'XULQJ ODVW SHULRG RI SUHJQDQF\ LWV

YDOXHVGLVWLQFWLYHO\GHFUHDVH6LPXOWDQHRXVO\SDUWXULWLRQUHOHDVHV

SLWXLWDU\*+1EORFNDGHDQGLWVFRQFHQWUDWLRQDQGUROHUHWXUQWR

OHYHOVEHIRUHSUHJQDQF\

The study financed by grant no. N N407 200037

References

1. Hennen G, Frankenne F, Closset J, [et al.]. A human placental GH: increasing levels during second half of pregnancy with pituitary GH suppression as revealed by monoclonal antibody radioimmunoassays. Int J Fertil. 1985, 30, 27-33.

2. Hennen G, Frankenne F, Pirens G, [et al.]. New chorionic GH-like antigen revealed by monoclonal antibody radioimmunoassays. Lancet. 1985, 1(8425), 399.

3. Barsh G, Seeburg P, Gelinas R. The human growth hormone gene family: structure and evolution of the chromosomal locus. Nucleic Acids Res. 1983, 11, 3939-3958.

4. Fuglsang J, Ovesen P. Aspects of placental growth hormone physiology. Growth Horm IGF Res.

2006, 16, 67-85.

5. Lacroix M, Guibourdenche J, Fournier T. Stimulation of human trophoblast invasion by placental growth hormone. Endocrinology. 2005, 146, 2434-2444.

6. Scippo M, Frankenne F, Hooghe-Peters E, [et al.]. Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol Cell Endocrinol. 1993, 92, 7-13.

7. Chellakooty M, Vangsgaard K, Larsen T, [et al.]. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation:

association between placental GH and fetal growth. J Clin Endocrinol Metab. 2004, 89, 384- 391.

8. Goluboff L, Ezrin C. Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab. 1969, 29, 1533-1538.

9. Stefaneanu L, Kovacs K, Lloyd R, [et al.]. Pituitary lactotrophs and somatotrophs in pregnancy:

a correlative in situ hybridization and immunocytochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992, 62, 291-296.

10. Mittal P, Hassan S, Espinoza J, [et al.]. The effect of gestational age and labor on placental growth hormone in amniotic fluid. Growth Horm IGF Res. 2008, 18, 174-179.

11. Kędzia A, Przybyszewska W. Grelina - nowy hormon zaangażowany w regulację wzrastania i homeostazę metaboliczną ustroju. Endokr Pediatr. 2007, 6, 53-60.

12. Christiansen M. Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome. Prenat Diagn. 2009, 29, 1249-1255.

13. Mittal P, Espinoza J, Hassan S, [et al.]. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J Matern Fetal Neonatal Med. 2007, 20, 651- 659.

14. Seremak-Mrozikiewicz A, Barlik M, Perlik M, [et al.]. Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia. Ginekol Pol 2011, 82, 363-370.

15. Lytras A, Bock M, Dodd J, Cattini P. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction. Endocrinology. 1994, 134, 2461-2467.

16. Untergasser G, Hermann M, Rumpold H, Berger P. Complex alternative splicing of the GH-V gene in the human testis. Eur J Endocrinol. 1998, 139, 424-427.

17. Sifakis S, Papadopoulou E, Konstantinidou A, [et al.]. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome. Growth Horm IGF Res. 2009, 19, 121-125.

K O M U N I K A T

Cytaty

Powiązane dokumenty

GH Overexpression of human GH in transgenic mice Increased incidence of mammary tumours (by activation of PRL receptor) IGF-I Overexpression of human IGF-I in epidermal cells..

The aim of this study was to determine whether there are significant differences in bone mineral density (BMD) and/or circadian levels of hormones connected with bone metabolism and

Introduction: In the search for biomarkers that allow the prediction of neonatal growth and development, placental growth hormone (PGH), pituitary growth hormone (GH1),

Hormonal replacement therapy with GH in Ames dwarf mice and with IGF-1 in GHRKO animals, as well as treatment of normal mice with large doses of GH, reduced the number of

Sportowcy często wykorzystują hormon wzrostu (GH, growth hormone) i insulinopodobny czynnik wzrostu 1 (IGF-1, insulin-like growth factor 1) w celach dopingowych.. Według

W warunkach in vitro oceniano wpływ GH (zastoso- wanego w stężeniu 0,1 mg/ml, 1,0 mg/ml lub 10 mg/ml) i IGF-I (zastosowanego w stężeniu 0,5 nM, 5,0 nM lub 50 nM) na aktywność

Introduction: The aim of the present study was to examine how weight loss treatment modulates plasma concentrations of ghrelin and insulin-like growth factor 1 (IGF-1) in obese

In patients before and after treatment and in healthy subjects fasting serum levels of total ghrelin, leptin, growth hormone (GH), insulin-like growth factor I